Upload
docsarsi
View
3.214
Download
5
Embed Size (px)
DESCRIPTION
Citation preview
Surgical Management of Glaucoma
Delivered by:
Cesar A. Perez, Jr. MD, DPBOPrepared by
Philippine Glaucoma SocietyThursday, April 7, 2011
2
Outline
• Overview• Trabeculectomy
– Indications, technique & post-operative care
• Laser iridotomy– Indications, technique & post-op care
Thursday, April 7, 2011
TRABECULECTOMY
Thursday, April 7, 2011
4
Indications for glaucoma surgery
Thursday, April 7, 2011
4
Indications for glaucoma surgery• Uncontrolled IOP or documented glaucomatous
progression in spite of maximum tolerated medical therapy
Thursday, April 7, 2011
4
Indications for glaucoma surgery• Uncontrolled IOP or documented glaucomatous
progression in spite of maximum tolerated medical therapy
• Poor compliance with medical therapy– Relative indication. Maximize compliance 1st
Thursday, April 7, 2011
4
Indications for glaucoma surgery• Uncontrolled IOP or documented glaucomatous
progression in spite of maximum tolerated medical therapy
• Poor compliance with medical therapy– Relative indication. Maximize compliance 1st
• Pupillary block angle closure glaucoma– Laser iridotomy 1st, then give medications if there is residual elevated IOP
Thursday, April 7, 2011
4
Indications for glaucoma surgery• Uncontrolled IOP or documented glaucomatous
progression in spite of maximum tolerated medical therapy
• Poor compliance with medical therapy– Relative indication. Maximize compliance 1st
• Pupillary block angle closure glaucoma– Laser iridotomy 1st, then give medications if there is residual elevated IOP
• Synechial angle closure for @ 360 degrees– May go straight to trabeculectomy
Thursday, April 7, 2011
4
Indications for glaucoma surgery• Uncontrolled IOP or documented glaucomatous
progression in spite of maximum tolerated medical therapy
• Poor compliance with medical therapy– Relative indication. Maximize compliance 1st
• Pupillary block angle closure glaucoma– Laser iridotomy 1st, then give medications if there is residual elevated IOP
• Synechial angle closure for @ 360 degrees– May go straight to trabeculectomy
• Congenital glaucoma– Definitive treatment is surgery
Thursday, April 7, 2011
Thursday, April 7, 2011
POAG
Thursday, April 7, 2011
POAG
Thursday, April 7, 2011
POAG
Medical Tx
Thursday, April 7, 2011
POAG PACG
Medical Tx
Thursday, April 7, 2011
POAG PACG
Medical Tx
Thursday, April 7, 2011
POAG PACG
Medical Tx
LaserIridotomy
Thursday, April 7, 2011
POAG PACG
Medical Tx
LaserIridotomy
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Medical Tx
LaserIridotomy
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Medical Tx
LaserIridotomy
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Medical Tx
LaserIridotomyTreat primary
cause, if possible
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Medical Tx
LaserIridotomyTreat primary
cause, if possible
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomyTreat primary
cause, if possible
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomyTreat primary
cause, if possible
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
Trabeculectomy + mitomycin-C
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
Trabeculectomy + mitomycin-C
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
•Any condition that has a high risk for failure for Trab w/ MMC - scarred superior conjunctivae - active proliferative membrane in the AC (e.g. epithelial ingrowth, NV) - active AC inflammation - multiple failed trabeculectomies
Trabeculectomy + mitomycin-C
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
•Any condition that has a high risk for failure for Trab w/ MMC - scarred superior conjunctivae - active proliferative membrane in the AC (e.g. epithelial ingrowth, NV) - active AC inflammation - multiple failed trabeculectomies
Trabeculectomy + mitomycin-C
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
•Any condition that has a high risk for failure for Trab w/ MMC - scarred superior conjunctivae - active proliferative membrane in the AC (e.g. epithelial ingrowth, NV) - active AC inflammation - multiple failed trabeculectomies
Trabeculectomy + mitomycin-C
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
•Any condition that has a high risk for failure for Trab w/ MMC - scarred superior conjunctivae - active proliferative membrane in the AC (e.g. epithelial ingrowth, NV) - active AC inflammation - multiple failed trabeculectomies
Trabeculectomy + mitomycin-C
Glaucoma drainage device, preferably by a GL specialist
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
•Any condition that has a high risk for failure for Trab w/ MMC - scarred superior conjunctivae - active proliferative membrane in the AC (e.g. epithelial ingrowth, NV) - active AC inflammation - multiple failed trabeculectomies
Poor visual Potential
(LP-NLP)
Trabeculectomy + mitomycin-C
Glaucoma drainage device, preferably by a GL specialist
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
•Any condition that has a high risk for failure for Trab w/ MMC - scarred superior conjunctivae - active proliferative membrane in the AC (e.g. epithelial ingrowth, NV) - active AC inflammation - multiple failed trabeculectomies
Poor visual Potential
(LP-NLP)
Trabeculectomy + mitomycin-C
Glaucoma drainage device, preferably by a GL specialist
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
•Any condition that has a high risk for failure for Trab w/ MMC - scarred superior conjunctivae - active proliferative membrane in the AC (e.g. epithelial ingrowth, NV) - active AC inflammation - multiple failed trabeculectomies
Poor visual Potential
(LP-NLP)
Trabeculectomy + mitomycin-C
Glaucoma drainage device, preferably by a GL specialist
Consider transcleral cyclophoto-
coagulation if w/ pain
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
•Any condition that has a high risk for failure for Trab w/ MMC - scarred superior conjunctivae - active proliferative membrane in the AC (e.g. epithelial ingrowth, NV) - active AC inflammation - multiple failed trabeculectomies
Poor visual Potential
(LP-NLP)
Trabeculectomy + mitomycin-C
Glaucoma drainage device, preferably by a GL specialist
Consider transcleral cyclophoto-
coagulation if w/ pain
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
•Any condition that has a high risk for failure for Trab w/ MMC - scarred superior conjunctivae - active proliferative membrane in the AC (e.g. epithelial ingrowth, NV) - active AC inflammation - multiple failed trabeculectomies
Poor visual Potential
(LP-NLP)
Trabeculectomy + mitomycin-C
Glaucoma drainage device, preferably by a GL specialist
Consider transcleral cyclophoto-
coagulation if w/ pain
Thursday, April 7, 2011
POAG PACGSecondary glaucoma
Congenital glaucoma
Medical Tx
LaserIridotomy
Refer to GL specialist: •Goniotomy, trabeculotomy, or combined trabeculotomy + trabeculectomy
Treat primary cause, if possible
No superior conjunctival scarring, relatively “quiet eye “; > 2y/o
•Any condition that has a high risk for failure for Trab w/ MMC - scarred superior conjunctivae - active proliferative membrane in the AC (e.g. epithelial ingrowth, NV) - active AC inflammation - multiple failed trabeculectomies
Poor visual Potential
(LP-NLP)
Trabeculectomy + mitomycin-C
Glaucoma drainage device, preferably by a GL specialist
Consider transcleral cyclophoto-
coagulation if w/ painLegend:
Uncontrolled IOP
Thursday, April 7, 2011
6
Traction suture
Thursday, April 7, 2011
6
Traction suture
Peripheral cornea
Thursday, April 7, 2011
6
Traction suture
Peripheral cornea Superior rectus
Thursday, April 7, 2011
7
Traction suture
• For good exposure of the surgical site
– Peripheral cornea• Concerns:
– Perforation of the cornea
– Superior rectus• Concerns:
– Greater potential for bleeding– Risk of ptosis post-op
Thursday, April 7, 2011
8
Conjunctival Peritomy: Fornix based
Thursday, April 7, 2011
9
Conjunctival Peritomy: Fornix based
• Easier to create
• Easier exposure & dissection of the sclera
• Creates a more posterior diffuse bleb
• May be more prone to leaks if not closed properly
Thursday, April 7, 2011
10
Conjunctival Peritomy: Limbal based
Thursday, April 7, 2011
11
Conjunctival Peritomy: Limbal based
• More difficult dissection & exposure
• Better water-tight closure
Thursday, April 7, 2011
12
Cauterization of episcleral vessels
Thursday, April 7, 2011
13
Removal of residual episcleral tissues
JA Tumbocon, MD
Thursday, April 7, 2011
14
Application of Anti-metabolites
Thursday, April 7, 2011
14
Application of Anti-metabolites• Mitomycin-C 2mg/ vial
– Concentration: 0.25 to 0.5 mg/ml– Duration: 1 to 5 minutes– Concentration & duration is dependent on the
appearance of the conjunctiva & presence of risk factors for failure
Thursday, April 7, 2011
14
Application of Anti-metabolites• Mitomycin-C 2mg/ vial
– Concentration: 0.25 to 0.5 mg/ml– Duration: 1 to 5 minutes– Concentration & duration is dependent on the
appearance of the conjunctiva & presence of risk factors for failure
• 5-Fluorouracil 250mg/ml– Intra-op: 0.5ml (25mg) to 1ml (50mg) for 5 mins– Post-op: 0.1ml (5mg) subconjunctival injection
daily for 7-14 days (Total dose not to exceed 50mg or 1ml.)
Thursday, April 7, 2011
15
Application of Anti-metabolites
Thursday, April 7, 2011
16
Irrigate copiously
Thursday, April 7, 2011
17
Scleral Flap Dissection
• 1/3 to 1/2 scleral thickness– Thinner flap = more
aqueous flow
• Shapes: – square, rectangular,
trapezoidal, triangular
Thursday, April 7, 2011
18
Scleral Flap Dissection
Thursday, April 7, 2011
19
Paracentesis
Thursday, April 7, 2011
20
Limbal Fistula
Thursday, April 7, 2011
21
Limbal FistulaDescemet’s punch
Thursday, April 7, 2011
22
Limbal Fistula Knife & Vannas scissors
Thursday, April 7, 2011
23
Limbal Fistula Knife & Vannas scissors
Thursday, April 7, 2011
24
Peripheral Iridectomy
Thursday, April 7, 2011
25
Peripheral Iridectomy
Thursday, April 7, 2011
26
Peripheral Iridectomy
• Iris usually prolapses through after creation of the the limbal fistula
• Iridectomy should be wider than the limbal fistula/ internal sclerectomy
• Better too wide than too small
Thursday, April 7, 2011
27
Scleral Flap closure
Thursday, April 7, 2011
28
Scleral Flap closure
• 10-0 Nylon suture
• May use 2 to 6 interrupted sutures
• Burry all suture knots
Thursday, April 7, 2011
29
Scleral Flap closure• No standard number or tightness
of sutures
• Should be able to visualize minimal aqueous flow through the borders of the scleral flap after AC reformation
– Add more sutures if there is excessive aqueous flow
– Loosen or remove sutures if there is no flow
• Better to err on the “tight side”
Thursday, April 7, 2011
30
Conjunctival Closure Limbal based peritomy
JA Tumbocon, MD
Thursday, April 7, 2011
31
Conjunctival Closure Fornix based peritomy
Thursday, April 7, 2011
32
Reform AC, note for elevation of the bleb & check for leaks
Thursday, April 7, 2011
JA Tumbocon, MD
Thursday, April 7, 2011
34
Trabeculectomy: Post-op care
Thursday, April 7, 2011
34
Trabeculectomy: Post-op care• Follow-up closely
– Success = 50% surgery + 50% post-op care
Thursday, April 7, 2011
34
Trabeculectomy: Post-op care• Follow-up closely
– Success = 50% surgery + 50% post-op care• Keep aqueous flowing
– Massage, laser suture lysis &/ or removal of releasable scleral flap sutures
Thursday, April 7, 2011
34
Trabeculectomy: Post-op care• Follow-up closely
– Success = 50% surgery + 50% post-op care• Keep aqueous flowing
– Massage, laser suture lysis &/ or removal of releasable scleral flap sutures
• Topical steroids (usually for 6-12 weeks)
Thursday, April 7, 2011
34
Trabeculectomy: Post-op care• Follow-up closely
– Success = 50% surgery + 50% post-op care• Keep aqueous flowing
– Massage, laser suture lysis &/ or removal of releasable scleral flap sutures
• Topical steroids (usually for 6-12 weeks)
• Prophylactic topical antibiotic
Thursday, April 7, 2011
34
Trabeculectomy: Post-op care• Follow-up closely
– Success = 50% surgery + 50% post-op care• Keep aqueous flowing
– Massage, laser suture lysis &/ or removal of releasable scleral flap sutures
• Topical steroids (usually for 6-12 weeks)
• Prophylactic topical antibiotic• + Cycloplegic agent (e.g. Atropine)
– Stabilizes blood-aqueous barrier– Pulls lens-iris diaphragm posteriorly
Thursday, April 7, 2011
35
Thursday, April 7, 2011
JA Tumbocon, MD
http://www.glaucomatoday.com/art/0305/0305sp.pdf
Thursday, April 7, 2011
Thank you
Thursday, April 7, 2011
Laser I r idotomy
Thursday, April 7, 2011
Laser Iridotomy• Mechanism
– Creates a bypass route for the aqueous to flow from the posterior to the anterior chamber & thus relieve relative or absolute pupillary block
• Lasers– Nd:YAG Laser– Argon Laser– Diode Laser
Thursday, April 7, 2011
Interruption of Pupillary block• Creation of a hole in the outer
half of the iris (iridotomy / iridectomy
– allows fluid from the PC to enter to the AC, bypassing the pupillary block
– equalization of pressure in both chambers
– peripheral iris falls posteriorly
– opens the appositionally closed angle
Thursday, April 7, 2011
41
Laser Iridotomy
• Indications:
– Relative pupillary block / primary angle closure
– Occludable angles– Occlusio pupillae– Fellow eye of patients w/ unilateral
angle closure (prophylactic L.I.)
Thursday, April 7, 2011
42
Laser Iridotomy• Other Indications:
– Nanophthalmos/ crowded “middle segment”
– Prevent pseudophakic or aphakic pupillary block
– With the use of post-vitrectomy silicone oil (inferior iridectomy)
– Can be used as initial therapy in:• Phacomorphic glaucoma
• Plateau iris
Thursday, April 7, 2011
43
Laser IridotomyPre-op evaluation: Gonioscopy
Closed angles Opens on indentation gonioscopy
Thursday, April 7, 2011
44
Laser Iridotomy
• Pre-laser medications– Brimonidine – Proparacaine– Pilocarpine (optional)
Thursday, April 7, 2011
45
Abraham lens
Magnifies view & has 4x laser beam minification (increases power concentration)
Thursday, April 7, 2011
Laser Iridotomy site
• Supero-temporal or supero-nasal peripheral iris
• Choose an iris crypt, if available
46
Thursday, April 7, 2011
47
Laser Iridotomy site
Thursday, April 7, 2011
48
Laser Iridotomy
• Nd: Yag (1064nm wavelength)
• Argon
• Frequency doubled CW Nd: YAG (532 nm wavelength / “Green Laser”)
• Diode
“ThermalLasers”
Thursday, April 7, 2011
49
Nd: YAG Laser Iridotomy
• Suggested Settings: – 2-6 mJ– 1-4 pulses / burst
• Less bursts for phakic eyes
– 2-4 bursts
Thursday, April 7, 2011
50
Nd: YAG Laser Iridotomy
• Advantages:– Fewer applications needed for
perforation– Less inflammation– Greater tendency to remain
patent
• Disadvantages:– Possibility of bleeding from the
treatment site
Thursday, April 7, 2011
51
Argon Laser Iridotomy Techniques
Thursday, April 7, 2011
52
Argon Laser Iridotomy Techniques“Chipping Technique”
• Suggested Settings: – Long pulse duration: 700-1500mW, 50 um, 0.2 secs– Short pulse duration: 1000-1500mW, 50 um,
0.02-0.05 secs
Thursday, April 7, 2011
52
Argon Laser Iridotomy Techniques“Chipping Technique”
• Suggested Settings: – Long pulse duration: 700-1500mW, 50 um, 0.2 secs– Short pulse duration: 1000-1500mW, 50 um,
0.02-0.05 secs
Thursday, April 7, 2011
53
Argon Laser Iridotomy Techniques“Hump technique”
– Suggested Settings: • “Hump”: 500mW, 500um, 0.5sec 1 burn only• Perforation: 1000mW, 50um, 0.2sec
Thursday, April 7, 2011
53
Argon Laser Iridotomy Techniques“Hump technique”
– Suggested Settings: • “Hump”: 500mW, 500um, 0.5sec 1 burn only• Perforation: 1000mW, 50um, 0.2sec
Thursday, April 7, 2011
54
Argon Laser Iridotomy Techniques“Drumhead technique”
– Suggested Settings: • Drumhead: 200mW, 200um, 0.2 sec, 4 burns• Perforation: 500mW, 50um, 0.2sec
Thursday, April 7, 2011
54
Argon Laser Iridotomy Techniques“Drumhead technique”
– Suggested Settings: • Drumhead: 200mW, 200um, 0.2 sec, 4 burns• Perforation: 500mW, 50um, 0.2sec
Thursday, April 7, 2011
55
Argon Laser Iridotomy
• Advantage:– Less potential for bleeding
• Disadvantage:– Requires more energy and more prone to
closure than Nd:YAG iridotomy
Thursday, April 7, 2011
56
Combined Argon & Nd: YAG Laser Iridotomy
• Suggested Settings:– Argon: Use “chipping, drumhead or hump” technique
settings to thin out the iris. – Nd:YAG for perforation: 1.5 - 5mJ, 1-2 pulses/burst,
1-2 burstsThursday, April 7, 2011
56
Combined Argon & Nd: YAG Laser Iridotomy
• Suggested Settings:– Argon: Use “chipping, drumhead or hump” technique
settings to thin out the iris. – Nd:YAG for perforation: 1.5 - 5mJ, 1-2 pulses/burst,
1-2 burstsThursday, April 7, 2011
57
Laser Iridotomy
• Endpoint
– Rush of pigment bearing aqueous through the iridectomy
– Deepening of the AC
– Presence of a retro-illuminated red reflex (not definite sign of a patent iridotomy)
– Visualization of anterior lens capsule through the iridectomy
Thursday, April 7, 2011
58
Laser Iridotomy
Thursday, April 7, 2011
59
Pre-L.I. Post-L.I.
Laser Iridotomy
Thursday, April 7, 2011
60
Laser Iridotomy
• Immediate post-laser – Check IOP hourly for at least 3 hours
(check for IOP spike)
– Topical steroids x 3-7 days
Thursday, April 7, 2011
61
Laser Iridotomy
• Potential Complications– IOP elevation– Persistent iritis– Corneal burns– Corectopia– Localized lenticular opacities– Posterior synechiae formation– Iris atrophy– Possibility of retinal burns (argon)– Late iridotomy closure
Thursday, April 7, 2011
62
Laser Iridotomy
• Post L.I. follow up– Patency of iridotomy– IOP – Gonioscopy: Monitor the irido-corneal angle.
May still close in spite of a patent iridotomy (possibly by other non-pupillary block mechanisms)
Long-term follow up is essential
Thursday, April 7, 2011
Thank you
Thursday, April 7, 2011